291 related articles for article (PubMed ID: 28974505)
1. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
Hashem H; Kumar AR; Müller I; Babor F; Bredius R; Dalal J; Hsu AP; Holland SM; Hickstein DD; Jolles S; Krance R; Sasa G; Taskinen M; Koskenvuo M; Saarela J; van Montfrans J; Wilson K; Bosch B; Moens L; Hershfield M; Meyts I;
Blood; 2017 Dec; 130(24):2682-2688. PubMed ID: 28974505
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.
Hashem H; Dimitrova D; Meyts I
Front Immunol; 2022; 13():932385. PubMed ID: 35911698
[TBL] [Abstract][Full Text] [Related]
4. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
5. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
6. Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Moens L; Hershfield M; Arts K; Aksentijevich I; Meyts I
Immunol Rev; 2019 Jan; 287(1):62-72. PubMed ID: 30565235
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of adenosine deaminase 2 (DADA2): Review.
Sharma V; Deo P; Sharma A
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
9. Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.
Schepp J; Proietti M; Frede N; Buchta M; Hübscher K; Rojas Restrepo J; Goldacker S; Warnatz K; Pachlopnik Schmid J; Duppenthaler A; Lougaris V; Uriarte I; Kelly S; Hershfield M; Grimbacher B
Arthritis Rheumatol; 2017 Aug; 69(8):1689-1700. PubMed ID: 28493328
[TBL] [Abstract][Full Text] [Related]
10. The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.
Barron KS; Aksentijevich I; Deuitch NT; Stone DL; Hoffmann P; Videgar-Laird R; Soldatos A; Bergerson J; Toro C; Cudrici C; Nehrebecky M; Romeo T; Jones A; Boehm M; Kanakry JA; Dimitrova D; Calvo KR; Alao H; Kapuria D; Ben-Yakov G; Pichard DC; Hathaway L; Brofferio A; McRae E; Moura NS; Schnappauf O; Rosenzweig S; Heller T; Cowen EW; Kastner DL; Ombrello AK
Front Immunol; 2021; 12():811473. PubMed ID: 35095905
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
12. Monogenic polyarteritis: the lesson of ADA2 deficiency.
Caorsi R; Penco F; Schena F; Gattorno M
Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
[TBL] [Abstract][Full Text] [Related]
13. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation.
Barzaghi F; Minniti F; Mauro M; Bortoli M; Balter R; Bonetti E; Zaccaron A; Vitale V; Omrani M; Zoccolillo M; Brigida I; Cicalese MP; Degano M; Hershfield MS; Aiuti A; Bondarenko AV; Chinello M; Cesaro S
Front Immunol; 2018; 9():2767. PubMed ID: 30692987
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Barzaghi F; Cicalese MP; Zoccolillo M; Brigida I; Barcella M; Merelli I; Sartirana C; Zanussi M; Calbi V; Bernardo ME; Tucci F; Migliavacca M; Giglio F; Doglio M; Canarutto D; Ferrua F; Consiglieri G; Prunotto G; Saettini F; Bonanomi S; Rovere-Querini P; Di Colo G; Jofra T; Fousteri G; Penco F; Gattorno M; Hershfield MS; Bongiovanni L; Ponzoni M; Marktel S; Milani R; Peccatori J; Ciceri F; Mortellaro A; Aiuti A
Front Immunol; 2022; 13():910021. PubMed ID: 36248833
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
[TBL] [Abstract][Full Text] [Related]
16. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.
Cuvelier GD; Rubin TS; Wall DA; Schroeder ML
J Clin Immunol; 2016 Oct; 36(7):713-24. PubMed ID: 27438785
[TBL] [Abstract][Full Text] [Related]
18. Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
Santo GC; Baldeiras I; Guerreiro R; Ribeiro JA; Cunha R; Youngstein T; Nanthapisal S; Leitão J; Fernandes C; Caramelo F; Almeida MDR; Brás J; Santana I;
Cerebrovasc Dis; 2018; 46(5-6):257-264. PubMed ID: 30645994
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern Era.
Ghimenton E; Flinn A; Lum SH; Leahy TR; Nademi Z; Owens S; Williams E; Flood T; Hambleton S; Slatter M; Gennery AR
J Clin Immunol; 2022 May; 42(4):819-826. PubMed ID: 35288820
[TBL] [Abstract][Full Text] [Related]
20. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
